The Lightning Round is extended in this CNBC.com exclusive feature.   Read More

This weekend, the US House of Representatives passed its version of health care reform and now awaits a version from the Senate.  The debate has been heating up since earlier this summer when President Obama was pushing for legislation before the summer recess.  Here are the biggest S&P Health Care gainers and losers over while the debate has waged on.   Read More

Cramer makes the call on viewers' favorite stocks.   Read More

Following are the day’s biggest winners and losers. Find out why shares of Nasdaq and JPMorgan popped while CBS and Boeing dropped.   Read More

Botox has been lifting brows in Hollywood for quite some time, but lately it’s been raising quite a few eyebrows in DC, as well!   Read More

The drug companies help pay my salary. Not directly, of course (although I bet there are conspiracy theorists out there who are probably convinced they do), but they undoubtedly contribute a sizeable amount of advertising dollars to the company I work for.    Read More

For years now, but especially in recent months, I've been covering the obesity epidemic. I regularly report on the statistics and the experimental drug data, detached and "objective" as I think any good reporter should be. It just didn't occur to me that the target population might include my sister.   Read More

It’s bathing suit time. Considering almost no one likes how they look nearly naked, what’s the trade?   Read More

Stocks pared their gains on Wednesday as banks pulled back but investors remained hopeful that the worst may be over for the economy. Treasury Secretary Timothy Geithner told a Senate panel that financial markets are "starting to heal" and that a program to remove toxic assets from bank balance sheets would begin in the next six weeks. Read and listen to what experts had to say...   Read More